ArticlePlant biotechnology journal2026
LUCID: An Integrative Approach for Target Discovery and dsRNA Design in Plant Fungal Pathogens.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Phytopathogenic fungi pose an escalating threat to global food security and ecosystem stability, as resistance and environmental concerns diminish the effectiveness of conventional fungicides. Double-stranded RNA (dsRNA)-based fungicides offer a species-specific, eco-friendly alternative. We introduce LUCID (Locating Uncovered, conserved, and Indispensable for pathogenicity Determinants), a computational pipeline that accelerates the development of RNAi-based biofungicides by integrating target identification with dsRNA design and off-target prediction. LUCID employs a dual-branch strategy to identify both Conserved Essential Proteins (CEPs) and Conserved Non-Annotated Proteins (CNAPs), leveraging transcriptomic data and comparative genomics across diverse fungal species. Validation in Botrytis cinerea demonstrated high efficacy, with 67% of proposed targets successfully silenced and an average silencing efficiency of 96%. Additionally, coupling LUCID with advanced protein language models (PLMs) revealed a novel pathogenicity determinant in B. cinerea: a putative mediator complex protein. LUCID offers a scalable, species-agnostic framework for designing sustainable fungicides, enabling rapid, targeted control of fungal diseases with minimal ecological impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.